Internal Medicine · Flushing, NY
NPI
1184891848
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13443 Maple Ave, C1d
Flushing, NY, 11355
Phone (718) 886-7588
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,058
94 services
Medicare patients, 2024
21
Average age 72
Drug cost, 2024
$2.6M
30,044 prescriptions
Company payments, 2025
$1,202
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jun Yang was code 99213 (office e&m - established), 38 times for 18 patients. In total Jun Yang billed 94 services in 10 codes, and Medicare paid $4,058.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 38 | 18 | $44.77 | $1,701 |
| 36415 Venipuncture Blood Collection | Office | 14 | 13 | $4.90 | $68.6 |
By year: 2022 $6,719 for 150 services; 2023 $5,931 for 134 services; 2024 $4,058 for 94 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 13 | $4.90 | $68.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Jun Yang prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 1,958 prescriptions and refills. In total Jun Yang wrote 30,044 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 1,958 | 2,106 | 240 | $693K |
| Amlodipine Besylate Generic | 1,890 | 2,132 | 210 | $7,509 |
| Atorvastatin Calcium Generic | 1,782 | 1,987 | 208 | $7,986 |
| Losartan Potassium Generic | 1,273 | 1,437 | 142 | $5,566 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 1,039 | 1,178 | 110 | $8,115 |
| Montelukast Sodium Generic | 910 | 974 | 169 | $4,466 |
| Tamsulosin Hcl Generic | 778 | 894 | 90 | $4,534 |
| Simvastatin Generic | 768 | 929 | 96 | $3,500 |
| Fenofibrate Fenofibrate,micronized | 752 | 856 | 79 | $6,072 |
| Alendronate Sodium Generic | 716 | 806 | 88 | $2,565 |
| Quetiapine Fumarate Generic | 707 | 772 | 102 | $3,088 |
| Metoprolol Succinate Generic | 682 | 746 | 73 | $4,059 |
| Donepezil Hcl Generic | 601 | 660 | 66 | $3,397 |
| Diclofenac Sodium Generic | 573 | 592 | 216 | $174K |
| Finasteride Generic | 554 | 641 | 59 | $2,318 |
Brand drugs: 4,782 claims; generic drugs: 24,721 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jun Yang $1,202 ($1,202 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $495.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 20 | $495 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $181 |
| Amgen Inc. AMGN | 7 | $144 |
| Exact Sciences Corporation EXAS | 5 | $129 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $77.05 |
| Esperion Therapeutics, Inc. ESPR | 4 | $76.43 |
| Abbvie Inc. ABBV | 1 | $29.77 |
| Ardelyx, Inc. ARDX | 1 | $25.4 |
| GlaxoSmithKline, LLC. GSK | 1 | $22.53 |
| Sanofi Pasteur Inc. SNY | 1 | $21.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.